Interleukin-7 (JL18008)

interleukin-7 · Jecho Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Interleukin-7 (JL18008), covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders [Phase 1]

See pricing